Brief: Vanda Pharmaceuticals Q4 EPS USD -0.08
13/02/2025 21:01
Feb 13 (Reuters) - Vanda Pharmaceuticals Q4 basic EPS USD -0.08. * Q4 operating income USD -10.279 million * Q4 net income USD -4.912 million * Q4 operating expenses USD 63.464 million
Recent news on Vanda Pharmaceuticals
See all newsUS STOCKS ON THE MOVE-Caterpillar, Kimberly-Clark, Bending Spoons
US STOCKS ON THE MOVE-Walmart, Super Micro, FMC
US STOCKS ON THE MOVE-Nvidia, Penske Automotive, ManpowerGroup
US STOCKS ON THE MOVE-Barrick Mining, Venture Global, GE Vernova
Vanda Pharma shares slip as trial failure halts anxiety drug program